LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
about
The evolution of poxvirus vaccinesHuman MonkeypoxEmergence and reemergence of vaccinia-like viruses: global scenario and perspectivesPreparedness for a smallpox pandemic in Japan: public health perspectives.A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.A novel highly reproducible and lethal nonhuman primate model for orthopox virus infectionACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines.Smallpox vaccine safety is dependent on T cells and not B cellsEffect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.Smallpox vaccines: targets of protective immunity.Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpoxSerological responses in humans to the smallpox vaccine LC16m8.Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques.The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.Animal poxvirus vaccines: a comprehensive review.A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012.Defending against smallpox: a focus on vaccines.The interplay between Araçatuba virus and host signaling pathways: role of PI3K/Akt in viral replication.Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky".Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
P2860
Q26995905-106CD901-9DE6-467D-87BC-26998820F1F9Q27023061-89E95D8C-4698-403C-A822-E60601EE2069Q28709918-F52C2799-DD15-4FF7-88E8-0D0E78014198Q30375511-2125ED1D-B135-4F14-8B96-090D44CAE6F8Q30445071-CB71DEA2-E226-4F27-8427-8F953D2B051CQ33573571-BFFDEDB0-2050-4E2F-A3D0-BEDA48B00CA7Q33892570-087C208F-A1E2-4C7E-8764-548C1B3CB00DQ34029293-0604D955-5B7A-42FA-905D-F0AC2DDEB20FQ34126697-BCEB2E6F-B1F9-4B4C-896F-175E6172A73BQ34260856-57B42914-67BC-4534-A762-94710DEFEEDEQ34443570-707ADA4A-5EA5-43D8-8EA5-86F5F60C0BDEQ34743303-4CE39240-448E-4266-AA86-72FDF31763EBQ34779016-7538ABAA-C51D-4027-94D2-C5C074629306Q34780607-87548209-D3B3-4E3B-BB19-1C04585E6FF3Q35152092-5BDEE4CA-D0A3-4C9B-BB95-392A21BA1F1BQ35557123-F978077C-D264-461A-83BC-E72447034C3FQ35826728-0504B127-460D-426E-B4DB-665EDD911323Q35909727-A87C0042-E825-4CA4-99AE-35CA804C71E0Q35945094-90A6FD80-5B67-47CA-9C13-6085D60531BEQ36631459-7E01E1F9-29E3-42CD-875C-843CBA89939BQ37169163-384AB78D-EC94-4A23-8921-0E5931604378Q37349246-5CF4FDE3-F99C-4772-8850-26B9817459FFQ37524022-48B9CB81-7BB1-4984-80C3-F1BAE432E077Q37791160-07EBA774-A23F-48D8-A291-267DCAE1779DQ38068233-56087023-2A07-4A9F-87C1-48D967123FBFQ38102696-098B4DD8-5029-4A1F-A19B-A943459A01B8Q38799357-42AC9909-C4BB-44DB-AFA4-C4924D6DA08EQ39511373-647F28E8-00B7-46C1-BC90-11B127696641Q42545129-7B0C4DFD-628C-4D94-AA53-8773ABCDB4FAQ45388494-7897100B-AC9D-48A4-A708-096F2E8D6280Q52688303-423A336C-475C-4F84-9E24-CBAD4E81A91D
P2860
LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@ast
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@en
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@nl
type
label
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@ast
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@en
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@nl
prefLabel
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@ast
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@en
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@nl
P2093
P2860
P50
P356
P1433
P1476
LC16m8, a highly attenuated va ...... rotects monkeys from monkeypox
@en
P2093
Hideki Hasegawa
Momoko Ogata
Naoko Iwata
Noriyo Nagata
Takeshi Kurata
Tetsuya Mizutani
Yasushi Ami
Yuriko Suzaki
P2860
P304
P356
10.1128/JVI.02642-05
P407
P577
2006-06-01T00:00:00Z